Darya-Varia Laboratoria Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Darya-Varia Laboratoria Tbk PT with three other
pharmaceutical manufacturers in Asia:
Suven Life Sciences Limited
sales of 5.10 billion Indian Rupees [US$77.87 million]
of which 97%
was Intermediaries under Contract Research/M),
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
(470.90 million Chinese Renmimbi [US$74.08 million]
Formosa Laboratories, Inc
based in Taiwan
(2.50 billion Taiwanese Dollars [US$75.66 million]
of which 100%
was Active Pharmaceutical Ingredient).
During the year ended December of 2014, sales at
Darya-Varia Laboratoria Tbk PT were 1.10 trillion Indonesian Rupiahs (US$75.39 million).
a very small
increase of 0.2%
versus 2013, when the company's sales were 1.10 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Darya-Varia Laboratoria Tbk PT
(and since 2009, sales have increased a total of 27%).
Sales of Toll Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
20.9% in 2014, from
193.19 billion Indonesian Rupiahs to 233.56 billion Indonesian Rupiahs.
Darya-Varia Laboratoria Tbk PT also saw significant increases in sales in
Prescribed Medicines (up 9.0% to 561.14 billion Indonesian Rupiahs)
Not all segments of Darya-Varia Laboratoria Tbk PT experienced an increase in sales in 2014:
sales of Consumer Health fell 21.5% to 309.12 billion Indonesian Rupiahs.